Illumina faces record European Union fine over Grail deal next week – report

Sundry Photography/iStock Editorial via Getty Images

illumina (Nasdaq: ILMN) a record fine from the European Union as early as next week after completing its purchase of cancer screening company Grail without the approval of the antitrust regulator.

The fine could reach $453 million, or 10% of the company’s revenue, according to the company

DealEuropeanfacesfineGrailIlluminaRecordReportunionweek
Comments (0)
Add Comment